Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

Item
http://www.wikidata.org/entity/Q26801221
The challenging interplay between rheumatoid arthritis, ageing and comorbidities.Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritisSampling: how to select participants in my research study?Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials.The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis.Primary Care Screening and Comorbidity Management in Rheumatoid Arthritis in Ontario, Canada.Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain.Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.Prevalence of co-morbidities and evaluation of their monitoring in Korean patients with rheumatoid arthritis: comparison with the results of an international, cross-sectional study (COMORA).Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis.A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial.Identification and Treatment Optimization of Comorbid Depression in Rheumatoid Arthritis.Comorbidities in Spondyloarthritis.Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis.Distinguishing rheumatoid arthritis from psoriatic arthritis
P2860

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

Item
http://www.wikidata.org/entity/Q26801221
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Evidence-based Recommendations ...... atology Comorbidity Initiative
@ast
Evidence-based Recommendations ...... atology Comorbidity Initiative
@en
Evidence-based Recommendations ...... atology Comorbidity Initiative
@nl
type
label
Evidence-based Recommendations ...... atology Comorbidity Initiative
@ast
Evidence-based Recommendations ...... atology Comorbidity Initiative
@en
Evidence-based Recommendations ...... atology Comorbidity Initiative
@nl
prefLabel
Evidence-based Recommendations ...... atology Comorbidity Initiative
@ast
Evidence-based Recommendations ...... atology Comorbidity Initiative
@en
Evidence-based Recommendations ...... atology Comorbidity Initiative
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P3181
P356
P1433
P1476
Evidence-based Recommendations ...... atology Comorbidity Initiative
@en
P2093
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P921